{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:46:29Z","timestamp":1792791989730,"version":"4.5.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["Edital Universal (401507\/2016-5)"],"award-info":[{"award-number":["Edital Universal (401507\/2016-5)"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12640-019-00053-7","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T06:02:46Z","timestamp":1557295366000},"page":"411-423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Creatine as a Neuroprotector: an Actor that Can Play Many Parts"],"prefix":"10.1007","volume":"36","author":[{"given":"Eduardo Peil","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela T.S.","family":"Wyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"key":"53_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.neulet.2017.12.020","volume":"665","author":"EM Adriano","year":"2018","unstructured":"Adriano EM, Gulino M, Arkel A, Salis G, Damonte N, Liessi E, Millo P, Garbati P, Balestrino M (2018) Di-acetyl creatine ethyl ester, a new creatine derivative for the possible treatment of creatine transporter deficiency. Neurosci Lett 665:217\u2013223. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2017.12.020","journal-title":"Neurosci Lett"},{"issue":"1","key":"53_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","volume":"136","author":"M Alam","year":"2002","unstructured":"Alam M, Schmidt WJ (2002) Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res 136(1):317\u2013324","journal-title":"Behav Brain Res"},{"issue":"29","key":"53_CR3","first-page":"273","volume":"4","author":"M AliMohammadi","year":"2015","unstructured":"AliMohammadi M, Eshraghian M, Zarindast MR, Aliaghaei A, Pishva H (2015) Effects of creatine supplementation on learning, memory retrieval, and apoptosis in an experimental animal model of Alzheimer disease. Med J Islam Repub Iran 4(29):273 eCollection 2015","journal-title":"Med J Islam Repub Iran"},{"issue":"4","key":"53_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ymgme.2006.06.006","volume":"89","author":"LS Almeida","year":"2006","unstructured":"Almeida LS, Rosenberg EH, Martinez-Mu\u00f1oz C, Verhoeven NM, Vilarinho L, Jakobs C, Salomons GS (2006) Overexpression of GAMT restores GAMT activity in primary GAMT-deficient fibroblasts. Mol Genet Metab 89(4):392\u2013394. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2006.06.006","journal-title":"Mol Genet Metab"},{"issue":"3","key":"53_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","volume":"8","author":"OA Andreassen","year":"2001","unstructured":"Andreassen OA, Dedeoglu A, Ferrante RJ, Jenkins BG, Ferrante KL, Thomas M, Friedlich A, Browne SE, Schilling G, Borchelt DR, Hersch SM, Ross CA, Beal MF (2001a) Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington\u2019s disease. Neurobiol Dis 8(3):479\u2013491","journal-title":"Neurobiol Dis"},{"issue":"2","key":"53_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1471-4159.2001.00188.x","volume":"77","author":"OA Andreassen","year":"2001","unstructured":"Andreassen OA, Jenkins BG, Dedeoglu A, Ferrante KL, Bogdanov MB, Kaddurah-Daouk R, Beal MF (2001b) Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation. J Neurochem 77(2):383\u2013390","journal-title":"J Neurochem"},{"issue":"8","key":"53_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3727\/000000005783982756","volume":"14","author":"RH Andres","year":"2005","unstructured":"Andres RH, Ducray AD, P\u00e9rez-Bouza A, Schlattner U, Huber AW, Krebs SH, Seiler RW, Wallimann T, Widmer HR (2005) Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system. Cell Transplant 14(8):537\u2013550","journal-title":"Cell Transplant"},{"issue":"16\u201317","key":"53_CR8","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.clinbiochem.2007.07.010","volume":"40","author":"A Arias","year":"2007","unstructured":"Arias A, Corbella M, Fons C, Sempere A, Garc\u00eda-Villoria J, Ormazabal A, Poo P, Pineda M, Vilaseca MA, Campistol J, Briones P, P\u00e0mpols T, Salomons GS, Ribes A, Artuch R (2007) Creatine transporter deficiency: prevalence among patients with mental retardation and pitfalls in metabolite screening. Clin Biochem 40(16\u201317):1328\u20131331. \n                    https:\/\/doi.org\/10.1016\/j.clinbiochem.2007.07.010","journal-title":"Clin Biochem"},{"issue":"2","key":"53_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2174\/1871527315666161104161855","volume":"16","author":"AH Attia","year":"2017","unstructured":"Attia AH, Gadelkarim M, Morsi M, Awad K, Elnenny M, Ghanem E, El-Jaafary S, Negida A (2017) Meta-analysis of creatine for neuroprotection against Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 16(2):169\u2013175. \n                    https:\/\/doi.org\/10.2174\/1871527315666161104161855","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"10","key":"53_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139967","volume":"10","author":"R Azeredo","year":"2015","unstructured":"Azeredo R, P\u00e9rez-S\u00e1nchez J, Sitj\u00e0-Bobadilla A, Fouz B, Tort L, Arag\u00e3o C, Oliva-Teles A, Costas B (2015) European sea bass (Dicentrarchus labrax) immune status and disease resistance are impaired by arginine dietary supplementation. PLoS One 10(10):e0139967. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0139967","journal-title":"PLoS One"},{"issue":"1","key":"53_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0006-8993(98)01131-7","volume":"816","author":"M Balestrino","year":"1999","unstructured":"Balestrino M, Rebaudo R, Lunardi G (1999) Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship. Brain Res 816(1):124\u2013130","journal-title":"Brain Res"},{"issue":"1","key":"53_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1389557515666150722102613","volume":"16","author":"RP Barcelos","year":"2016","unstructured":"Barcelos RP, Stefanello ST, Mauriz JL, Gonzalez-Gallego J, Soares FA (2016) Creatine and the liver: metabolism and possible interactions. Mini-Rev Med Chem 16(1):12\u201318","journal-title":"Mini-Rev Med Chem"},{"issue":"2","key":"53_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00726-007-0582-4","volume":"35","author":"RA Bassit","year":"2008","unstructured":"Bassit RA, Curi R, Costa Rosa LF (2008) Creatine supplementation reduces plasma levels of pro-inflammatory cytokines and PGE2 after a half-ironman competition. Amino Acids 35(2):425\u2013431. \n                    https:\/\/doi.org\/10.1007\/s00726-007-0582-4","journal-title":"Amino Acids"},{"issue":"5","key":"53_CR14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00421-009-1305-1","volume":"108","author":"RA Bassit","year":"2010","unstructured":"Bassit RA, Pinheiro CH, Vitzel KF, Sproesser AJ, Silveira LR, Curi R (2010) Effect of short-term creatine supplementation on markers of skeletal muscle damage after strenuous contractile activity. Eur J Appl Physiol 108(5):945\u2013955. \n                    https:\/\/doi.org\/10.1007\/s00421-009-1305-1","journal-title":"Eur J Appl Physiol"},{"issue":"6","key":"53_CR15","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jpeds.2006.01.043","volume":"148","author":"R Battini","year":"2006","unstructured":"Battini R, Alessandr\u00ec MG, Leuzzi V, Moro F, Tosetti M, Bianchi MC, Cioni G (2006) Arginine:glycine amidinotransferase (AGAT) deficiency in a newborn: early treatment can prevent phenotypic expression of the disease. J Pediatr 148(6):828\u2013830. \n                    https:\/\/doi.org\/10.1016\/j.jpeds.2006.01.043","journal-title":"J Pediatr"},{"issue":"4","key":"53_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/ana.20624","volume":"58","author":"MF Beal","year":"2005","unstructured":"Beal MF (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58(4):495\u2013505. \n                    https:\/\/doi.org\/10.1002\/ana.20624","journal-title":"Ann Neurol"},{"issue":"2","key":"53_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1471-4159.2010.06935.x","volume":"115","author":"E B\u00e9ard","year":"2010","unstructured":"B\u00e9ard E, Braissant O (2010) Synthesis and transport of creatine in the CNS: importance for cerebral functions. J Neurochem 115(2):297\u2013313. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06935.x","journal-title":"J Neurochem"},{"issue":"8","key":"53_CR18","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s00726-015-2165-0","volume":"48","author":"A Bender","year":"2016","unstructured":"Bender A, Klopstock T (2016) Creatine for neuroprotection in neurodegenerative disease: end of story? Amino Acids 48(8):1929\u20131940. \n                    https:\/\/doi.org\/10.1007\/s00726-015-2165-0","journal-title":"Amino Acids"},{"issue":"1","key":"53_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00415-005-0595-4","volume":"252","author":"A Bender","year":"2005","unstructured":"Bender A, Auer DP, Merl T, Reilmann R, Saemann P, Yassouridis A, Bender J, Weindl A, Dose T, Gasser M, Klopstock T (2005) Creatine supplementation lowers brain glutamate levels in Huntington\u2019s disease. J Neurol 252(1):36\u201341. \n                    https:\/\/doi.org\/10.1007\/s00415-005-0595-4","journal-title":"J Neurol"},{"issue":"7","key":"53_CR20","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1212\/01.wnl.0000238518.34389.12","volume":"67","author":"A Bender","year":"2006","unstructured":"Bender A, Koch W, Elstner M, Schombacher Y, Bender J, Moeschl M, Gekeler F, Muller-Myhsok B, Gasser T, Tatsch K, Klopstock T (2006) Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial. Neurology 67(7):1262\u20131264. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000238518.34389.12","journal-title":"Neurology"},{"issue":"9","key":"53_CR21","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.neurobiolaging.2007.03.001","volume":"29","author":"A Bender","year":"2008","unstructured":"Bender A, Beckers J, Schneider I, H\u00f6lter SM, Haack T, Ruthsatz T, Vogt-Weisenhorn DM, Becker L, Genius J, Rujescu D, Irmler M, Mijalski T, Mader M, Quintanilla-Martinez L, Fuchs H, Gailus-Durner V, de Angelis MH, Wurst W, Schmidt J, Klopstock T (2008) Creatine improves health and survival of mice. Neurobiol Aging 29(9):1404\u20131411. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.03.001","journal-title":"Neurobiol Aging"},{"issue":"9533","key":"53_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer\u2019s disease. Lancet 368(9533):387\u2013403. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(06)69113-7","journal-title":"Lancet"},{"issue":"4","key":"53_CR23","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10545-011-9433-2","volume":"35","author":"O Braissant","year":"2012","unstructured":"Braissant O (2012) Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers. J Inherit Metab Dis 35(4):655\u2013664. \n                    https:\/\/doi.org\/10.1007\/s10545-011-9433-2","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"53_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s10545-008-0826-9","volume":"31","author":"O Braissant","year":"2008","unstructured":"Braissant O, Henry H (2008) AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review. J Inherit Metab Dis 31(2):230\u2013239. \n                    https:\/\/doi.org\/10.1007\/s10545-008-0826-9","journal-title":"J Inherit Metab Dis"},{"issue":"1\u20132","key":"53_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0169-328X(00)00269-2","volume":"86","author":"O Braissant","year":"2001","unstructured":"Braissant O, Henry H, Loup M, Eilers B, Bachmann C (2001) Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study. Brain Res Mol Brain Res 86(1\u20132):193\u2013201","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"53_CR26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.nbd.2009.10.022","volume":"37","author":"O Braissant","year":"2010","unstructured":"Braissant O, B\u00e9ard E, Torrent C, Henry H (2010) Dissociation of AGAT, GAMT and SLC6A8 in CNS: relevance to creatine deficiency syndromes. Neurobiol Dis 37(2):423\u2013433. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2009.10.022","journal-title":"Neurobiol Dis"},{"issue":"5","key":"53_CR27","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1046\/j.1471-4159.2000.0741968.x","volume":"74","author":"GJ Brewer","year":"2000","unstructured":"Brewer GJ, Wallimann TW (2000) Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J Neurochem 74(5):1968\u20131978","journal-title":"J Neurochem"},{"key":"53_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1146\/annurev.nutr.27.061406.093621","volume":"27","author":"JT Brosnan","year":"2007","unstructured":"Brosnan JT, Brosnan ME (2007) Creatine: endogenous metabolite, dietary, and therapeutic supplement. Annu Rev Nutr 27:241\u2013261. \n                    https:\/\/doi.org\/10.1146\/annurev.nutr.27.061406.093621","journal-title":"Annu Rev Nutr"},{"issue":"8","key":"53_CR29","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s00726-016-2188-1","volume":"48","author":"ME Brosnan","year":"2016","unstructured":"Brosnan ME, Brosnan JT (2016) The role of dietary creatine. Amino Acids 48(8):1785\u20131791. \n                    https:\/\/doi.org\/10.1007\/s00726-016-2188-1","journal-title":"Amino Acids"},{"issue":"3","key":"53_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.nbd.2006.01.001","volume":"22","author":"SE Browne","year":"2006","unstructured":"Browne SE, Yang L, DiMauro JP, Fuller SW, Licata SC, Beal MF (2006) Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiol Dis 22(3):599\u2013610. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2006.01.001","journal-title":"Neurobiol Dis"},{"issue":"1","key":"53_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ab.2005.12.015","volume":"350","author":"EF Burguera","year":"2006","unstructured":"Burguera EF, Love BJ (2006) Reduced transglutaminase-catalyzed protein aggregation is observed in the presence of creatine using sedimentation velocity. Anal Biochem 350(1):113\u2013119. \n                    https:\/\/doi.org\/10.1016\/j.ab.2005.12.015","journal-title":"Anal Biochem"},{"issue":"3","key":"53_CR32","doi-asserted-by":"publisher","first-page":"35936","DOI":"10.1155\/JBB\/2006\/35936","volume":"2006","author":"TS B\u00fcrklen","year":"2006","unstructured":"B\u00fcrklen TS, Schlattner U, Homayouni R, Gough K, Rak M, Szeghalmi A, Wallimann T (2006) The creatine kinase\/creatine connection to Alzheimer\u2019s disease: CK-inactivation, APP-CK complexes and focal creatine deposits. J Biomed Biotechnol 2006(3):35936\u201335911. \n                    https:\/\/doi.org\/10.1155\/JBB\/2006\/35936","journal-title":"J Biomed Biotechnol"},{"issue":"14","key":"53_CR33","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1523\/JNEUROSCI.21-14-05110.2001","volume":"21","author":"P Calabresi","year":"2001","unstructured":"Calabresi P, Gubellini P, Picconi B, Centonze D, Pisani A, Bonsi P, Greengard P, Hipskind RA, Borrelli E, Bernardi G (2001) Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. J Neurosci 21(14):5110\u20135120","journal-title":"J Neurosci"},{"issue":"2 Suppl","key":"53_CR34","doi-asserted-by":"publisher","first-page":"607S","DOI":"10.1093\/ajcn\/72.2.607S","volume":"72","author":"A Casey","year":"2000","unstructured":"Casey A, Greenhaff PL (2000) Does dietary creatine supplementation play a role in skeletal muscle metabolism and performance? Am J Clin Nutr 72(2 Suppl):607S\u2013617S. \n                    https:\/\/doi.org\/10.1093\/ajcn\/72.2.607S","journal-title":"Am J Clin Nutr"},{"key":"53_CR35","doi-asserted-by":"publisher","unstructured":"Cella PS, Marinello PC, Borges FH, Ribeiro DF, Chimin P, Testa MTJ, Guirro PB, Duarte JA, Cecchini R, Guarnier FA, Deminice R (2019) Creatine supplementation in Walker-256 tumor-bearing rats prevents skeletal muscle atrophy by attenuating systemic inflammation and protein degradation signaling. Eur J Nutr. \n                    https:\/\/doi.org\/10.1007\/s00394-019-01933-6","DOI":"10.1007\/s00394-019-01933-6"},{"issue":"6","key":"53_CR36","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1523\/JNEUROSCI.1941-16.2016","volume":"37","author":"KA Chamberlain","year":"2017","unstructured":"Chamberlain KA, Chapey KS, Nanescu SE, Huang JK (2017) Creatine enhances mitochondrial-mediated oligodendrocyte survival after demyelinating injury. J Neurosci 37(6):1479\u20131492. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1941-16.2016","journal-title":"J Neurosci"},{"issue":"4","key":"53_CR37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1017\/S0007114513003012","volume":"111","author":"RP da Silva","year":"2014","unstructured":"da Silva RP, Clow K, Brosnan JT, Brosnan ME (2014) Synthesis of guanidinoacetate and creatine from amino acids by rat pancreas. Br J Nutr 111(4):571\u2013577. \n                    https:\/\/doi.org\/10.1017\/S0007114513003012","journal-title":"Br J Nutr"},{"issue":"2","key":"53_CR38","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1152\/jappl.2001.90.2.586","volume":"90","author":"HW De Gouw","year":"2001","unstructured":"De Gouw HW, Marshall-Partridge SJ, Van Der Veen H, Van Den Aardweg JG, Hiemstra PS, Sterk PJ (2001) Role of nitric oxide in the airway response to exercise in healthy and asthmatic subjects. J Appl Physiol (1985) 90(2):586\u2013592. \n                    https:\/\/doi.org\/10.1152\/jappl.2001.90.2.586","journal-title":"J Appl Physiol (1985)"},{"issue":"4","key":"53_CR39","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0006-3495(00)76717-8","volume":"78","author":"RA de Graaf","year":"2000","unstructured":"de Graaf RA, van Kranenburg A, Nicolay K (2000) In vivo (31)P-NMR diffusion spectroscopy of ATP and phosphocreatine in rat skeletal muscle. Biophys J 78(4):1657\u20131664. \n                    https:\/\/doi.org\/10.1016\/S0006-3495(00)76717-8","journal-title":"Biophys J"},{"issue":"3","key":"53_CR40","doi-asserted-by":"publisher","first-page":"R698","DOI":"10.1152\/ajpregu.1999.277.3.R698","volume":"277","author":"P Dechent","year":"1999","unstructured":"Dechent P, Pouwels PJ, Wilken B, Hanefeld F, Frahm J (1999) Increase of total creatine in human brain after oral supplementation of creatine-monohydrate. Am J Phys 277(3):R698\u2013R704. \n                    https:\/\/doi.org\/10.1152\/ajpregu.1999.277.3.R698","journal-title":"Am J Phys"},{"issue":"6","key":"53_CR41","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1046\/j.1471-4159.2003.01706.x","volume":"85","author":"A Dedeoglu","year":"2003","unstructured":"Dedeoglu A, Kubilus JK, Yang L, Ferrante KL, Hersch SM, Beal MF, Ferrante RJ (2003) Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington\u2019s disease transgenic mice. J Neurochem 85(6):1359\u20131367","journal-title":"J Neurochem"},{"issue":"2","key":"53_CR42","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00726-011-1121-x","volume":"43","author":"R Deminice","year":"2012","unstructured":"Deminice R, Jordao AA (2012) Creatine supplementation reduces oxidative stress biomarkers after acute exercise in rats. Amino Acids 43(2):709\u2013715. \n                    https:\/\/doi.org\/10.1007\/s00726-011-1121-x","journal-title":"Amino Acids"},{"issue":"9","key":"53_CR43","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.nut.2013.03.003","volume":"29","author":"R Deminice","year":"2013","unstructured":"Deminice R, Rosa FT, Franco GS, Jordao AA, de Freitas EC (2013) Effects of creatine supplementation on oxidative stress and inflammatory markers after repeated-sprint exercise in humans. Nutrition 29(9):1127\u20131132. \n                    https:\/\/doi.org\/10.1016\/j.nut.2013.03.003","journal-title":"Nutrition"},{"issue":"20","key":"53_CR44","doi-asserted-by":"publisher","first-page":"17760","DOI":"10.1074\/jbc.M208705200","volume":"278","author":"M Dolder","year":"2003","unstructured":"Dolder M, Walzel B, Speer O, Schlattner U, Wallimann T (2003) Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J Biol Chem 278(20):17760\u201317766. \n                    https:\/\/doi.org\/10.1074\/jbc.M208705200","journal-title":"J Biol Chem"},{"issue":"1","key":"53_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/146608202317576534","volume":"3","author":"VE Drory","year":"2002","unstructured":"Drory VE, Gross D (2002) No effect of creatine on respiratory distress in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 3(1):43\u201346. \n                    https:\/\/doi.org\/10.1080\/146608202317576534","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"30","key":"53_CR46","doi-asserted-by":"publisher","first-page":"11159","DOI":"10.1073\/pnas.0402026101","volume":"101","author":"L Dupuis","year":"2004","unstructured":"Dupuis L, Oudart H, Ren\u00e9 F, Gonzalez de Aguilar JL, Loeffler JP (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A 101(30):11159\u201311164. \n                    https:\/\/doi.org\/10.1073\/pnas.0402026101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"53_CR47","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","volume":"20","author":"RJ Ferrante","year":"2000","unstructured":"Ferrante RJ, Andreassen OA, Jenkins BG, Dedeoglu A, Kuemmerle S, Kubilus JK, Kaddurah-Daouk R, Hersch SM, Beal MF (2000) Neuroprotective effects of creatine in a transgenic mouse model of Huntington\u2019s disease. J Neurosci 20(12):4389\u20134397","journal-title":"J Neurosci"},{"issue":"12","key":"53_CR48","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1055\/s-0030-1267160","volume":"31","author":"SC Ferreira","year":"2010","unstructured":"Ferreira SC, Toledo AC, Hage M, Santos A, Medeiros M, Martins M, Carvalho C, Dolhnikoff M, Vieira R (2010) Creatine activates airway epithelium in asthma. Int J Sports Med 31(12):906\u2013912. \n                    https:\/\/doi.org\/10.1055\/s-0030-1267160","journal-title":"Int J Sports Med"},{"key":"53_CR49","doi-asserted-by":"publisher","unstructured":"Garcia M, Santos-Dias A, Bachi A, Carneiro M, Santos A, C\u00e9sar Ferreira S, Comin, J, Almeida, F, Rigonato-Oliveira N, Oliveira A, Savio L, Coutinho-Silva R,\u00a0 M\u00fcller T, Idzko M, Siepmann T, and Vieira R (2019) Creatine supplementation impairs airway inflammation in an experimental model of asthma involving P2 \u00d7 7 receptor. Eur J Immunol [Epub ahead of print]. \n                    https:\/\/doi.org\/10.1002\/eji.201847657","DOI":"10.1002\/eji.201847657"},{"issue":"4","key":"53_CR50","first-page":"267","volume":"87","author":"JD Gazewood","year":"2013","unstructured":"Gazewood JD, Richards DR, Clebak K (2013) Parkinson disease: an update. Am Fam Physician 87(4):267\u2013273","journal-title":"Am Fam Physician"},{"key":"53_CR51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1749-6632.1999.tb07827.x","volume":"893","author":"T Gr\u00fcnewald","year":"1999","unstructured":"Gr\u00fcnewald T, Beal MF (1999) Bioenergetics in Huntington\u2019s disease. Ann N Y Acad Sci 893:203\u2013213","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"53_CR52","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbagen.2007.09.018","volume":"1780","author":"C Guidi","year":"2008","unstructured":"Guidi C, Potenza L, Sestili P, Martinelli C, Guescini M, Stocchi L, Zeppa S, Polidori E, Annibalini G, Stocchi V (2008) Differential effect of creatine on oxidatively-injured mitochondrial and nuclear DNA. Biochim Biophys Acta 1780(1):16\u201326. \n                    https:\/\/doi.org\/10.1016\/j.bbagen.2007.09.018","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"53_CR53","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1007\/s00421-012-2378-9","volume":"112","author":"L Guimar\u00e3es-Ferreira","year":"2012","unstructured":"Guimar\u00e3es-Ferreira L, Pinheiro CH, Gerlinger-Romero F, Vitzel KF, Nachbar RT, Curi R, Nunes MT (2012) Short-term creatine supplementation decreases reactive oxygen species content with no changes in expression and activity of antioxidant enzymes in skeletal muscle. Eur J Appl Physiol 112(11):3905\u20133911. \n                    https:\/\/doi.org\/10.1007\/s00421-012-2378-9","journal-title":"Eur J Appl Physiol"},{"key":"53_CR54","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.nbd.2015.03.029","volume":"79","author":"L Hanna-El-Daher","year":"2015","unstructured":"Hanna-El-Daher L, B\u00e9ard E, Henry H, Tenenbaum L, Braissant O (2015) Mild guanidinoacetate increase under partial guanidinoacetate methyltransferase deficiency strongly affects brain cell development. Neurobiol Dis 79:14\u201327. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2015.03.029","journal-title":"Neurobiol Dis"},{"issue":"2","key":"53_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/1545968306293449","volume":"21","author":"CJ Hass","year":"2007","unstructured":"Hass CJ, Collins MA, Juncos JL (2007) Resistance training with creatine monohydrate improves upper-body strength in patients with Parkinson disease: a randomized trial. Neurorehabil Neural Repair 21(2):107\u2013115. \n                    https:\/\/doi.org\/10.1177\/1545968306293449","journal-title":"Neurorehabil Neural Repair"},{"issue":"2","key":"53_CR56","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","volume":"66","author":"SM Hersch","year":"2006","unstructured":"Hersch SM, Gevorkian S, Marder K, Moskowitz C, Feigin A, Cox M, Como P, Zimmerman C, Lin M, Zhang L, Ulug AM, Beal MF, Matson W, Bogdanov M, Ebbel E, Zaleta A, Kaneko Y, Jenkins B, Hevelone N, Zhang H, Yu H, Schoenfeld D, Ferrante R, Rosas HD (2006) Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2\u2019dG. Neurology 66(2):250\u2013252. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000194318.74946.b6","journal-title":"Neurology"},{"issue":"6","key":"53_CR57","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1212\/WNL.0000000000004209","volume":"89","author":"SM Hersch","year":"2017","unstructured":"Hersch SM, Schifitto G, Oakes D, Bredlau AL, Meyers CM, Nahin R, Rosas HD, Huntington Study Group CREST-E Investigators and Coordinators (2017) The CREST-E study of creatine for Huntington disease: a randomized controlled trial. Neurology 89(6):594\u2013601. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004209","journal-title":"Neurology"},{"issue":"9","key":"53_CR58","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1007\/s11064-010-0198-z","volume":"35","author":"R Hosamani","year":"2010","unstructured":"Hosamani R, Ramesh SR, Muralidhara (2010) Attenuation of rotenone-induced mitochondrial oxidative damage and neurotoxicty in Drosophila melanogaster supplemented with creatine. Neurochem Res 35(9):1402\u20131412. \n                    https:\/\/doi.org\/10.1007\/s11064-010-0198-z","journal-title":"Neurochem Res"},{"issue":"5","key":"53_CR59","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1086\/323765","volume":"69","author":"CB Item","year":"2001","unstructured":"Item CB, St\u00f6ckler-Ipsiroglu S, Stromberger C, M\u00fchl A, Alessandr\u00ec MG, Bianchi MC, Tosetti M, Fornai F, Cioni G (2001) Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet 69(5):1127\u20131133. \n                    https:\/\/doi.org\/10.1086\/323765","journal-title":"Am J Hum Genet"},{"issue":"2","key":"53_CR60","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.pop.2015.01.005","volume":"42","author":"KE Johnson","year":"2015","unstructured":"Johnson KE (2015) Approach to the patient with Parkinson disease. Prim Care 42(2):205\u2013215. \n                    https:\/\/doi.org\/10.1016\/j.pop.2015.01.005","journal-title":"Prim Care"},{"key":"53_CR61","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.biochi.2015.10.022","volume":"119","author":"M Joncquel-Chevalier Curt","year":"2015","unstructured":"Joncquel-Chevalier Curt M, Voicu PM, Fontaine M, Dessein AF, Porchet F, Mention-Mulliez K, Dobbelaere D, Soto-Ares G, Cheillan D, Vamecq J (2015) Creatine biosynthesis and transport in health and disease. Biochimie 119:146\u2013165. \n                    https:\/\/doi.org\/10.1016\/j.biochi.2015.10.022","journal-title":"Biochimie"},{"key":"53_CR62","doi-asserted-by":"publisher","unstructured":"Jones R (2013) Oligodendrocyte loss in ALS. Nat Rev Neurosci 14:308 \n                    https:\/\/doi.org\/10.1038\/nrn3498","DOI":"10.1038\/nrn3498"},{"issue":"10","key":"53_CR63","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1046\/j.1460-9568.2002.02001.x","volume":"15","author":"CR Jost","year":"2002","unstructured":"Jost CR, Van Der Zee CE, In\u2019t Zandt HJ, Oerlemans F, Verheij M, Streijger F, Fransen J, Heerschap A, Cools AR, Wieringa B (2002) Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility. Eur J Neurosci 15(10):1692\u20131706","journal-title":"Eur J Neurosci"},{"issue":"5\u20136","key":"53_CR64","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1159\/000111452","volume":"18","author":"P Kaldis","year":"1996","unstructured":"Kaldis P, Hemmer W, Zanolla E, Holtzman D, Wallimann T (1996) \u2018Hot spots\u2019 of creatine kinase localization in brain: cerebellum, hippocampus and choroid plexus. Dev Neurosci 18(5\u20136):542\u2013554. \n                    https:\/\/doi.org\/10.1159\/000111452","journal-title":"Dev Neurosci"},{"issue":"2","key":"53_CR65","first-page":"340","volume":"231","author":"NK Khanna","year":"1978","unstructured":"Khanna NK, Madan BR (1978) Studies on the anti-inflammatory activity of creatine. Arch Int Pharmacodyn Ther 231(2):340\u2013350","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"6","key":"53_CR66","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1001\/jama.2015.120","volume":"313","author":"K Kieburtz","year":"2015","unstructured":"Kieburtz K, Tilley BC, Elm JJ et al (2015) Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. JAMA 313(6):584\u2013593. \n                    https:\/\/doi.org\/10.1001\/jama.2015.120","journal-title":"JAMA"},{"issue":"4","key":"53_CR67","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/WCO.0000000000000116","volume":"27","author":"SD Kim","year":"2014","unstructured":"Kim SD, Fung VS (2014) An update on Huntington\u2019s disease: from the gene to the clinic. Curr Opin Neurol 27(4):477\u2013483. \n                    https:\/\/doi.org\/10.1097\/WCO.0000000000000116","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"53_CR68","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1046\/j.1471-4159.2003.02160.x","volume":"88","author":"P Klivenyi","year":"2004","unstructured":"Klivenyi P, Kiaei M, Gardian G, Calingasan NY, Beal MF (2004) Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem 88(3):576\u2013582","journal-title":"J Neurochem"},{"issue":"1","key":"53_CR69","first-page":"68","volume":"14","author":"AJ Koch","year":"2014","unstructured":"Koch AJ, Pereira R, Machado M (2014) The creatine kinase response to resistance exercise. J Musculoskelet Neuronal Interact 14(1):68\u201377","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"1","key":"53_CR70","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2005.01.004","volume":"132","author":"Y Koga","year":"2005","unstructured":"Koga Y, Takahashi H, Oikawa D, Tachibana T, Denbow DM, Furuse M (2005) Brain creatine functions to attenuate acute stress responses through GABAnergic system in chicks. Neuroscience 132(1):65\u201371. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2005.01.004","journal-title":"Neuroscience"},{"issue":"3","key":"53_CR71","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s11011-010-9215-9","volume":"25","author":"J Kolling","year":"2010","unstructured":"Kolling J, Wyse ATS (2010) Creatine prevents the inhibition of energy metabolism and lipid peroxidation in rats subjected to GAA administration. Metab Brain Dis 25(3):331\u2013338. \n                    https:\/\/doi.org\/10.1007\/s11011-010-9215-9","journal-title":"Metab Brain Dis"},{"issue":"1","key":"53_CR72","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.gene.2014.05.005","volume":"545","author":"J Kolling","year":"2014","unstructured":"Kolling J, Scherer EB, Siebert C, Marques EP, Dos Santos TM, Wyse ATS (2014) Creatine prevents the imbalance of redox homeostasis caused by homocysteine in skeletal muscle of rats. Gene 545(1):72\u201379. \n                    https:\/\/doi.org\/10.1016\/j.gene.2014.05.005","journal-title":"Gene"},{"issue":"4","key":"53_CR73","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s12640-017-9767-0","volume":"32","author":"J Kolling","year":"2017","unstructured":"Kolling J, Longoni A, Siebert C, Dos Santos TM, Marques EP, Carletti J, Pereira LO, Wyse ATS (2017) Severe Hyperhomocysteinemia decreases Creatine kinase activity and causes memory impairment: neuroprotective role of Creatine. Neurotox Res 32(4):585\u2013593. \n                    https:\/\/doi.org\/10.1007\/s12640-017-9767-0","journal-title":"Neurotox Res"},{"key":"53_CR74","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12970-017-0173-z","volume":"14","author":"RB Kreider","year":"2017","unstructured":"Kreider RB, Kalman DS, Antonio J, Ziegenfuss TN, Wildman R, Collins R, Candow DG, Kleiner SM, Almada AL, Lopez HL (2017) International Society of Sports Nutrition position stand: safety and efficacy of creatinesupplementation in exercise, sport, and medicine. J Int Soc Sports Nutr 14:18. \n                    https:\/\/doi.org\/10.1186\/s12970-017-0173-z","journal-title":"J Int Soc Sports Nutr"},{"issue":"1","key":"53_CR75","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1006\/bbrc.2001.6164","volume":"290","author":"JM Lawler","year":"2002","unstructured":"Lawler JM, Barnes WS, Wu G, Song W, Demaree S (2002) Direct antioxidant properties of creatine. Biochem Biophys Res Commun 290(1):47\u201352. \n                    https:\/\/doi.org\/10.1006\/bbrc.2001.6164","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"53_CR76","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.intimp.2011.04.018","volume":"11","author":"KM Leland","year":"2011","unstructured":"Leland KM, McDonald TL, Drescher KM (2011) Effect of creatine, creatinine, and creatine ethyl ester on TLR expression in macrophages. Int Immunopharmacol 11(9):1341\u20131347. \n                    https:\/\/doi.org\/10.1016\/j.intimp.2011.04.018","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"53_CR77","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.0022-202X.2004.23522.x","volume":"124","author":"H Lenz","year":"2005","unstructured":"Lenz H, Schmidt M, Welge V, Schlattner U, Wallimann T, Els\u00e4sser HP, Wittern KP, Wenck H, St\u00e4b F, Blatt T (2005) The creatine kinase system in human skin: protective effects of creatine against oxidative and UV damage in vitro and in vivo. J Invest Dermatol 124(2):443\u2013452. \n                    https:\/\/doi.org\/10.1111\/j.0022-202X.2004.23522.x","journal-title":"J Invest Dermatol"},{"issue":"3\u20134","key":"53_CR78","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000377676","volume":"73","author":"Z Li","year":"2015","unstructured":"Li Z, Wang P, Yu Z, Cong Y, Sun H, Zhang J, Zhang J, Sun C, Zhang Y, Ju X (2015) The effect of creatine and coenzyme q10 combination therapy on mild cognitive impairment in Parkinson\u2019s disease. Eur Neurol 73(3\u20134):205\u2013211. \n                    https:\/\/doi.org\/10.1159\/000377676","journal-title":"Eur Neurol"},{"issue":"2","key":"53_CR79","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0925-4927(03)00046-5","volume":"123","author":"IK Lyoo","year":"2003","unstructured":"Lyoo IK, Kong SW, Sung SM, Hirashima F, Parow A, Hennen J, Cohen BM, Renshaw PF (2003) Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate. Psychiatry Res 123(2):87\u2013100","journal-title":"Psychiatry Res"},{"issue":"1","key":"53_CR80","first-page":"1","volume":"23","author":"BR Madan","year":"1979","unstructured":"Madan BR, Khanna NK (1979) Effect of creatinine on various experimentally induced inflammatory models. Indian J Physiol Pharmacol 23(1):1\u20137","journal-title":"Indian J Physiol Pharmacol"},{"issue":"1","key":"53_CR81","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0014-5793(75)80966-5","volume":"55","author":"E Magri","year":"1975","unstructured":"Magri E, Baldoni G, Grazi E (1975) On the biosynthesis of creatine. Intramitochondrial localization of transamidinase from rat kidney. FEBS Lett 55(1):91\u201393","journal-title":"FEBS Lett"},{"key":"53_CR82","doi-asserted-by":"publisher","first-page":"232640981666937","DOI":"10.1177\/2326409816669371","volume":"4","author":"E Marques","year":"2016","unstructured":"Marques E, Wyse ATS (2016) Guanidinoacetate methyltransferase deficiency. J Inborn Errors Metabol Screen 4:232640981666937. \n                    https:\/\/doi.org\/10.1177\/2326409816669371","journal-title":"J Inborn Errors Metabol Screen"},{"key":"53_CR83","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/B978-0-12-385883-2.00005-9","volume":"107","author":"LJ Martin","year":"2012","unstructured":"Martin LJ (2012) Biology of mitochondria in neurodegenerative diseases. Prog Mol Biol Transl Sci 107:355\u2013415. \n                    https:\/\/doi.org\/10.1016\/B978-0-12-385883-2.00005-9","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"1","key":"53_CR84","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1523\/JNEUROSCI.18-01-00156.1998","volume":"18","author":"RT Matthews","year":"1998","unstructured":"Matthews RT, Yang L, Jenkins BG, Ferrante RJ, Rosen BR, Kaddurah-Daouk R, Beal MF (1998) Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington\u2019s disease. J Neurosci 18(1):156\u2013163","journal-title":"J Neurosci"},{"issue":"3","key":"53_CR85","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3233\/JAD-160488","volume":"54","author":"PL McGeer","year":"2016","unstructured":"McGeer PL, Rogers J, McGeer EG (2016) Inflammation, Antiinflammatory agents, and Alzheimer\u2019s disease: the last 22 years. J Alzheimers Dis 54(3):853\u2013857. \n                    https:\/\/doi.org\/10.3233\/JAD-160488","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"53_CR86","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.physbeh.2006.08.024","volume":"90","author":"T McMorris","year":"2007","unstructured":"McMorris T, Harris RC, Howard AN, Langridge G, Hall B, Corbett J, Dicks M, Hodgson C (2007) Creatine supplementation, sleep deprivation, cortisol, melatonin and behavior. Physiol Behav 90(1):21\u201328. \n                    https:\/\/doi.org\/10.1016\/j.physbeh.2006.08.024","journal-title":"Physiol Behav"},{"issue":"49","key":"53_CR87","doi-asserted-by":"publisher","first-page":"37361","DOI":"10.1074\/jbc.M604123200","volume":"281","author":"LE Meyer","year":"2006","unstructured":"Meyer LE, Machado LB, Santiago AP, Da-Silva WS, de Felice FG, Holub O, Oliveira MF, Galina A (2006) Mitochondrial creatine kinase activity prevents reactive oxygen species generation: antioxidant role of mitochondrial kinase-dependent ADP re-cycling activity. J Biol Chem 281(49):37361\u201337371. \n                    https:\/\/doi.org\/10.1074\/jbc.M604123200","journal-title":"J Biol Chem"},{"issue":"1","key":"53_CR88","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12883-017-0885-3","volume":"17","author":"JJ Mo","year":"2017","unstructured":"Mo JJ, Liu LY, Peng WB, Rao J, Liu Z, Cui LL (2017) The effectiveness of creatine treatment for Parkinson\u2019s disease: an updated meta-analysis of randomized controlled trials. BMC Neurol 17(1):105. \n                    https:\/\/doi.org\/10.1186\/s12883-017-0885-3","journal-title":"BMC Neurol"},{"issue":"4","key":"53_CR89","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/sj.bjp.0705316","volume":"139","author":"A Nomura","year":"2003","unstructured":"Nomura A, Zhang M, Sakamoto T, Ishii Y, Morishima Y, Mochizuki M, Kimura T, Uchida Y, Sekizawa K (2003) Anti-inflammatory activity of creatine supplementation in endothelial cells in vitro. Br J Pharmacol 139(4):715\u2013720. \n                    https:\/\/doi.org\/10.1038\/sj.bjp.0705316","journal-title":"Br J Pharmacol"},{"issue":"3","key":"53_CR90","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1073\/pnas.85.3.694","volume":"85","author":"H Ogawa","year":"1988","unstructured":"Ogawa H, Date T, Gomi T, Konishi K, Pitot HC, Cantoni GL, Fujioka M (1988) Molecular cloning, sequence analysis, and expression in Escherichia coli of the cDNA for guanidinoacetate methyltransferase from rat liver. Proc Natl Acad Sci U S A 85(3):694\u2013698","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5518","key":"53_CR91","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1126\/science.1059162","volume":"292","author":"SH Oliet","year":"2001","unstructured":"Oliet SH, Piet R, Poulain DA (2001) Control of glutamate clearance and synaptic efficacy by glial coverage of neurons. Science 292(5518):923\u2013926. \n                    https:\/\/doi.org\/10.1126\/science.1059162","journal-title":"Science"},{"issue":"1","key":"53_CR92","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.bbr.2007.09.004","volume":"187","author":"MS Oliveira","year":"2008","unstructured":"Oliveira MS, Furian AF, Fighera MR, Fiorenza NG, Ferreira J, Rubin MA, Mello CF, Royes LF (2008) The involvement of the polyamines binding sites at the NMDA receptor in creatine-induced spatial learning enhancement. Behav Brain Res 187(1):200\u2013204. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2007.09.004","journal-title":"Behav Brain Res"},{"issue":"3","key":"53_CR93","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00232-005-0813-0","volume":"207","author":"MN Orsenigo","year":"2005","unstructured":"Orsenigo MN, Faelli A, DeBiase S, Sironi C, Laforenza U, Paulmichl M, Tosco M (2005) Jejunal creatine absorption: what is the role of the basolateral membrane? J Membr Biol 207(3):183\u2013195. \n                    https:\/\/doi.org\/10.1007\/s00232-005-0813-0","journal-title":"J Membr Biol"},{"key":"53_CR94","doi-asserted-by":"publisher","first-page":"CD005225","DOI":"10.1002\/14651858.CD005225.pub3","volume":"12","author":"DM Pastula","year":"2012","unstructured":"Pastula DM, Moore DH, Bedlack RS (2012) Creatine for amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database Syst Rev 12:CD005225. \n                    https:\/\/doi.org\/10.1002\/14651858.CD005225.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"Pt 1","key":"53_CR95","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1113\/jphysiol.2002.026377","volume":"545","author":"MJ Peral","year":"2002","unstructured":"Peral MJ, Garc\u00eda-Delgado M, Calonge ML, Dur\u00e1n JM, De La Horra MC, Wallimann T, Speer O, Ilund\u00e1in A (2002) Human, rat and chicken small intestinal Na+ - Cl- -creatine transporter: functional, molecular characterization and localization. J Physiol 545(Pt 1):133\u2013144","journal-title":"J Physiol"},{"issue":"11","key":"53_CR96","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s004150050272","volume":"245","author":"N Quinn","year":"1998","unstructured":"Quinn N, Schrag A (1998) Huntington's disease and other choreas. J Neurol 245(11):709\u2013716","journal-title":"J Neurol"},{"issue":"1529","key":"53_CR97","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1098\/rspb.2003.2492","volume":"270","author":"C Rae","year":"2003","unstructured":"Rae C, Digney AL, McEwan SR, Bates TC (2003) Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial. Proc Biol Sci 270(1529):2147\u20132150. \n                    https:\/\/doi.org\/10.1098\/rspb.2003.2492","journal-title":"Proc Biol Sci"},{"key":"53_CR98","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.intimp.2015.12.034","volume":"37","author":"LA Riesberg","year":"2016","unstructured":"Riesberg LA, Weed SA, McDonald TL, Eckerson JM, Drescher KM (2016) Beyond muscles: the untapped potential of creatine. Int Immunopharmacol 37:31\u201342. \n                    https:\/\/doi.org\/10.1016\/j.intimp.2015.12.034","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"53_CR99","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1212\/WNL.0000000000000187","volume":"82","author":"HD Rosas","year":"2014","unstructured":"Rosas HD, Doros G, Gevorkian S, Malarick K, Reuter M, Coutu JP, Triggs TD, Wilkens PJ, Matson W, Salat DH, Hersch SM (2014) PRECREST: a phase II prevention and biomarker trial of creatine in at-risk Huntington disease. Neurology 82(10):850\u2013857 \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000000187","journal-title":"Neurology"},{"issue":"5","key":"53_CR100","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/17482960802028890","volume":"9","author":"J Rosenfeld","year":"2008","unstructured":"Rosenfeld J, King RM, Jackson CE, Bedlack RS, Barohn RJ, Dick A, Phillips LH, Chapin J, Gelinas DF, Lou JS (2008) Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and ALSFRS. Amyotroph Lateral Scler 9(5):266\u2013272. \n                    https:\/\/doi.org\/10.1080\/17482960802028890","journal-title":"Amyotroph Lateral Scler"},{"issue":"1","key":"53_CR101","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.pbb.2005.12.017","volume":"83","author":"LF Royes","year":"2006","unstructured":"Royes LF, Fighera MR, Furian AF, Oliveira MS, Myskiw JC, Fiorenza NG, Petry JC, Coelho RC, Mello CF (2006) Effectiveness of creatine monohydrate on seizures and oxidative damage induced by methylmalonate. Pharmacol Biochem Behav 83(1):136\u2013144. \n                    https:\/\/doi.org\/10.1016\/j.pbb.2005.12.017","journal-title":"Pharmacol Biochem Behav"},{"issue":"1\u20132","key":"53_CR102","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neuint.2008.04.008","volume":"53","author":"LF Royes","year":"2008","unstructured":"Royes LF, Fighera MR, Furian AF et al (2008) Neuromodulatory effect of creatine on extracellular action potentials in rat hippocampus: role of NMDA receptors. Neurochem Int 53(1\u20132):33\u201337. \n                    https:\/\/doi.org\/10.1016\/j.neuint.2008.04.008","journal-title":"Neurochem Int"},{"issue":"2","key":"53_CR103","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/01.ta.0000230269.46108.d5","volume":"61","author":"G Sakellaris","year":"2006","unstructured":"Sakellaris G, Kotsiou M, Tamiolaki M, Kalostos G, Tsapaki E, Spanaki M, Spilioti M, Charissis G, Evangeliou A (2006) Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration: an open label randomized pilot study. J Trauma 61(2):322\u2013329. \n                    https:\/\/doi.org\/10.1097\/01.ta.0000230269.46108.d5","journal-title":"J Trauma"},{"issue":"6","key":"53_CR104","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1086\/320595","volume":"68","author":"GS Salomons","year":"2001","unstructured":"Salomons GS, van Dooren SJ, Verhoeven NM, Cecil KM, Ball WS, Degrauw TJ, Jakobs C (2001) X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet 68(6):1497\u20131500. \n                    https:\/\/doi.org\/10.1086\/320595","journal-title":"Am J Hum Genet"},{"issue":"16","key":"53_CR105","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.lfs.2003.11.036","volume":"75","author":"RV Santos","year":"2004","unstructured":"Santos RV, Bassit RA, Caperuto EC, Costa Rosa LF (2004) The effect of creatine supplementation upon inflammatory and muscle soreness markers after a 30km race. Life Sci 75(16):1917\u20131924. \n                    https:\/\/doi.org\/10.1016\/j.lfs.2003.11.036","journal-title":"Life Sci"},{"issue":"3","key":"53_CR106","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ymben.2003.11.004","volume":"6","author":"U Sauer","year":"2004","unstructured":"Sauer U, Schlattner U (2004) Inverse metabolic engineering with phosphagen kinase systems improves the cellular energy state. Metab Eng 6(3):220\u2013228. \n                    https:\/\/doi.org\/10.1016\/j.ymben.2003.11.004","journal-title":"Metab Eng"},{"key":"53_CR107","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fnins.2015.00123","volume":"9","author":"NR Saunders","year":"2015","unstructured":"Saunders NR, Dziegielewska KM, M\u00f8llg\u00e5rd K, Habgood MD, Wakefield MJ, Lindsay H, Stratzielle N, Ghersi-Egea JF, Liddelow SA (2015) Influx mechanisms in the embryonic and adult rat choroid plexus: a transcriptome study. Front Neurosci 9:123. \n                    https:\/\/doi.org\/10.3389\/fnins.2015.00123","journal-title":"Front Neurosci"},{"issue":"2","key":"53_CR108","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1023\/B:NERE.0000013753.22615.59","volume":"29","author":"SW Scheff","year":"2004","unstructured":"Scheff SW, Dhillon HS (2004) Creatine-enhanced diet alters levels of lactate and free fatty acids after experimental brain injury. Neurochem Res 29(2):469\u2013479","journal-title":"Neurochem Res"},{"issue":"2","key":"53_CR109","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.bbadis.2005.09.004","volume":"1762","author":"U Schlattner","year":"2006","unstructured":"Schlattner U, Tokarska-Schlattner M, Wallimann T (2006) Mitochondrial creatine kinase in human health and disease. Biochim Biophys Acta 1762(2):164\u2013180. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2005.09.004","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"53_CR110","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.freeradbiomed.2005.10.035","volume":"40","author":"P Sestili","year":"2006","unstructured":"Sestili P, Martinelli C, Bravi G, Piccoli G, Curci R, Battistelli M, Falcieri E, Agostini D, Gioacchini AM, Stocchi V (2006) Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity. Free Radic Biol Med 40(5):837\u2013849. \n                    https:\/\/doi.org\/10.1016\/j.freeradbiomed.2005.10.035","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"53_CR111","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1212\/01.WNL.0000142992.81995.F0","volume":"63","author":"JM Shefner","year":"2004","unstructured":"Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, Urbinelli L, Qureshi M, Zhang H, Pestronk A, Caress J, Donofrio P, Sorenson E, Bradley W, Lomen-Hoerth C, Pioro E, Rezania K, Ross M, Pascuzzi R, Heiman-Patterson T, Tandan R, Mitsumoto H, Rothstein J, Smith-Palmer T, MacDonald D, Burke D, the NEALS Consortium (2004) A clinical trial of creatine in ALS. Neurology 63(9):1656\u20131661","journal-title":"Neurology"},{"issue":"2","key":"53_CR112","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.nbd.2012.03.037","volume":"47","author":"H Shen","year":"2012","unstructured":"Shen H, Goldberg MP (2012) Creatine pretreatment protects cortical axons from energy depletion in vitro. Neurobiol Dis 47(2):184\u2013193. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2012.03.037","journal-title":"Neurobiol Dis"},{"issue":"8","key":"53_CR113","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nn1503","volume":"8","author":"EM Snyder","year":"2005","unstructured":"Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8(8):1051\u20131058. \n                    https:\/\/doi.org\/10.1038\/nn1503","journal-title":"Nat Neurosci"},{"issue":"1","key":"53_CR114","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/ajcn\/83.1.5","volume":"83","author":"LM Stead","year":"2006","unstructured":"Stead LM, Brosnan JT, Brosnan ME, Vance DE, Jacobs RL (2006) Is it time to reevaluate methyl balance in humans? Am J Clin Nutr 83(1):5\u201310. \n                    https:\/\/doi.org\/10.1093\/ajcn\/83.1.5","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"53_CR115","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1550-2783-11-11","volume":"11","author":"GP Stefani","year":"2014","unstructured":"Stefani GP, Nunes RB, Dornelles AZ, Alves JP, Piva MO, Domenico MD, Rhoden CR, Lago PD (2014) Effects of creatine supplementation associated with resistance training on oxidative stress in different tissues of rats. J Int Soc Sports Nutr 11(1):11. \n                    https:\/\/doi.org\/10.1186\/1550-2783-11-11","journal-title":"J Int Soc Sports Nutr"},{"issue":"3","key":"53_CR116","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1203\/00006450-199409000-00023","volume":"36","author":"S St\u00f6ckler","year":"1994","unstructured":"St\u00f6ckler S, Holzbach U, Hanefeld F, Marquardt I, Helms G, Requart M, H\u00e4nicke W, Frahm J (1994) Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res 36(3):409\u2013413. \n                    https:\/\/doi.org\/10.1203\/00006450-199409000-00023","journal-title":"Pediatr Res"},{"issue":"2","key":"53_CR117","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bbr.2004.07.002","volume":"157","author":"F Streijger","year":"2005","unstructured":"Streijger F, Oerlemans F, Ellenbroek BA, Jost CR, Wieringa B, Van der Zee CE (2005) Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit. Behav Brain Res 157(2):219\u2013234. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2004.07.002","journal-title":"Behav Brain Res"},{"issue":"9","key":"53_CR118","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1212\/01.WNL.0000160388.96242.77","volume":"64","author":"SJ Tabrizi","year":"2005","unstructured":"Tabrizi SJ, Blamire AM, Manners DN, Rajagopalan B, Styles P, Schapira AH, Warner TT (2005) High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study. Neurology 64(9):1655\u20131656. \n                    https:\/\/doi.org\/10.1212\/01.WNL.0000160388.96242.77","journal-title":"Neurology"},{"issue":"1","key":"53_CR119","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pneurobio.2008.01.001","volume":"85","author":"BJ Turner","year":"2008","unstructured":"Turner BJ, Talbot K (2008) Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol 85(1):94\u2013134. \n                    https:\/\/doi.org\/10.1016\/j.pneurobio.2008.01.001","journal-title":"Prog Neurobiol"},{"issue":"4","key":"53_CR120","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1523\/JNEUROSCI.3113-14.2015","volume":"35","author":"CE Turner","year":"2015","unstructured":"Turner CE, Byblow WD, Gant N (2015) Creatine supplementation enhances corticomotor excitability and cognitive performance during oxygen deprivation. J Neurosci 35(4):1773\u20131780. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3113-14.2015","journal-title":"J Neurosci"},{"issue":"1","key":"53_CR121","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbr.2008.08.004","volume":"197","author":"B Valastro","year":"2009","unstructured":"Valastro B, Dekundy A, Danysz W, Quack G (2009) Oral creatine supplementation attenuates L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats. Behav Brain Res 197(1):90\u201396. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2008.08.004","journal-title":"Behav Brain Res"},{"issue":"1","key":"53_CR122","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10545-011-9358-9","volume":"35","author":"V Valayannopoulos","year":"2012","unstructured":"Valayannopoulos V, Boddaert N, Chabli A, Barbier V, Desguerre I, Philippe A, Afenjar A, Mazzuca M, Cheillan D, Munnich A, de Keyzer Y, Jakobs C, Salomons GS, de Lonlay P (2012) Treatment by oral creatine, L-arginine and L-glycine in six severely affected patients with creatine transporter defect. J Inherit Metab Dis 35(1):151\u2013157. \n                    https:\/\/doi.org\/10.1007\/s10545-011-9358-9","journal-title":"J Inherit Metab Dis"},{"issue":"12","key":"53_CR123","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1007\/s00415-011-6099-5","volume":"258","author":"SJ van den Bogaard","year":"2011","unstructured":"van den Bogaard SJ, Dumas EM, Teeuwisse WM, Kan HE, Webb A, Roos RA, van der Grond J (2011) Exploratory 7-tesla magnetic resonance spectroscopy in Huntington\u2019s disease provides in vivo evidence for impaired energy metabolism. J Neurol 258(12):2230\u20132239. \n                    https:\/\/doi.org\/10.1007\/s00415-011-6099-5","journal-title":"J Neurol"},{"issue":"7","key":"53_CR124","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1212\/01.WNL.0000090629.40891.4B","volume":"61","author":"P Verbessem","year":"2003","unstructured":"Verbessem P, Lemiere J, Eijnde BO, Swinnen S, Vanhees L, Van Leemputte M, Hespel P, Dom R (2003) Creatine supplementation in Huntington\u2019s disease: a placebo-controlled pilot trial. Neurology 61(7):925\u2013930","journal-title":"Neurology"},{"issue":"6","key":"53_CR125","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1165\/rcmb.2007-0108OC","volume":"37","author":"RP Vieira","year":"2007","unstructured":"Vieira RP, Duarte AC, Claudino RC et al (2007) Creatine supplementation exacerbates allergic lung inflammation and airway remodeling in mice. Am J Respir Cell Mol Biol 37(6):660\u2013667. \n                    https:\/\/doi.org\/10.1165\/rcmb.2007-0108OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"53_CR126","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1055\/s-0029-1224176","volume":"30","author":"RP Vieira","year":"2009","unstructured":"Vieira RP, Duarte AC, Santos AB, Medeiros MC, Mauad T, Martins MA, Carvalho CR, Dolhnikoff M (2009) Exercise reduces effects of creatine on lung. Int J Sports Med 30(9):684\u2013690. \n                    https:\/\/doi.org\/10.1055\/s-0029-1224176","journal-title":"Int J Sports Med"},{"issue":"5","key":"53_CR127","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00726-011-0877-3","volume":"40","author":"T Wallimann","year":"2011","unstructured":"Wallimann T, Tokarska-Schlattner M, Schlattner U (2011) The creatine kinase system and pleiotropic effects of creatine. Amino Acids 40(5):1271\u20131296. \n                    https:\/\/doi.org\/10.1007\/s00726-011-0877-3","journal-title":"Amino Acids"},{"issue":"4","key":"53_CR128","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0168-0102(02)00007-X","volume":"42","author":"A Watanabe","year":"2002","unstructured":"Watanabe A, Kato N, Kato T (2002) Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res 42(4):279\u2013285","journal-title":"Neurosci Res"},{"issue":"9","key":"53_CR129","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S0891-5849(02)00784-0","volume":"32","author":"S Wendt","year":"2002","unstructured":"Wendt S, Dedeoglu A, Speer O, Wallimann T, Beal MF, Andreassen OA (2002) Reduced creatine kinase activity in transgenic amyotrophic lateral sclerosis mice. Free Radic Biol Med 32(9):920\u2013926","journal-title":"Free Radic Biol Med"},{"key":"53_CR130","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1750-1172-4-3","volume":"4","author":"LC Wijesekera","year":"2009","unstructured":"Wijesekera LC, Leigh PN (2009) Amyotrophic lateral sclerosis. Orphanet J Rare Dis 4:3. \n                    https:\/\/doi.org\/10.1186\/1750-1172-4-3","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"53_CR131","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11011-011-9246-x","volume":"26","author":"ATS Wyse","year":"2011","unstructured":"Wyse ATS, Netto CA (2011) Behavioral and neurochemical effects of proline. Metab Brain Dis 26(3):159\u2013172. \n                    https:\/\/doi.org\/10.1007\/s11011-011-9246-x","journal-title":"Metab Brain Dis"},{"issue":"3","key":"53_CR132","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","volume":"80","author":"M Wyss","year":"2000","unstructured":"Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80(3):1107\u20131213","journal-title":"Physiol Rev"},{"issue":"2","key":"53_CR133","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0306-4522(02)00088-X","volume":"112","author":"M Wyss","year":"2002","unstructured":"Wyss M, Schulze A (2002) Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease? Neuroscience 112(2):243\u2013260","journal-title":"Neuroscience"},{"key":"53_CR134","doi-asserted-by":"publisher","first-page":"CD009646","DOI":"10.1002\/14651858.CD009646.pub2","volume":"6","author":"Y Xiao","year":"2014","unstructured":"Xiao Y, Luo M, Luo H, Wang J (2014) Creatine for Parkinson\u2019s disease. Cochrane Database Syst Rev 6:CD009646. \n                    https:\/\/doi.org\/10.1002\/14651858.CD009646.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"53_CR135","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/j.1471-4159.2009.06074.x","volume":"109","author":"L Yang","year":"2009","unstructured":"Yang L, Calingasan NY, Wille EJ, Cormier K, Smith K, Ferrante RJ, Beal MF (2009) Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson\u2019s and Huntington\u2019s diseases. J Neurochem 109(5):1427\u20131439. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06074.x","journal-title":"J Neurochem"},{"key":"53_CR136","doi-asserted-by":"publisher","unstructured":"Young JF, Larsen LB, Malmendal A, Nielsen NC, Straadt IK, Oksbjerg N, and Bertram HC (2010) Creatine-induced activation of antioxidative defence in myotube cultures revealed by explorative NMR-based metabonomics and proteomics.\u00a0 J Int Soc Sports Nutr 7 (1):9 \n                    https:\/\/doi.org\/10.1186\/1550-2783-7-9","DOI":"10.1186\/1550-2783-7-9"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00053-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-019-00053-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00053-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T23:06:12Z","timestamp":1588806372000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-019-00053-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":136,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1007\/s12640-019-00053-7","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"assertion":[{"value":"20 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}